Communiqués Waverley Pharma Inc.

Actions

WAVE

CA94357L1058

Marché Fermé - Toronto S.E. Autres places de cotation 20:10:16 27/06/2024			Varia. 5j.	Varia. 1 janv.
0,02 ^CAD	-42,86 %		-42,86 %	-20,00 %

20/06	Waverley Pharma Inc. élit James Kinley au poste d'administrateur	CI
29/05	Waverley Pharma Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Waverley Pharma Announces Annual and Special Meeting Election Results	20/06	AQ
Waverley Pharma : Notice of meeting	23/05	PU
Waverley Pharma : Information circular	23/05	PU
Waverley Pharma Business Update	01/05	AQ
Waverley Pharma Announces Changes to Board of Directors	22/11	AQ
Waverley Pharma Business Update	02/08/23	AQ
Waverley Pharma Provides Business Update	20/03/23	AQ
Waverley Pharma Provides Update on its PARP-1 Inhibitor Program	11/01/23	AQ
Waverley Pharma : Announces $3,000,000 Credit Facility	05/08/21	AQ
Waverley Pharma : Announces Successful Tender Award for Pemetrexed with NHS England	27/05/21	AQ
Waverley Pharma : Announces Successful Tender Award for Capecitabine with NHS Scotland	18/01/21	AQ
Waverley Pharma : Announces Tentative ANDA Approval for Pemetrexed in the United States	12/11/20	AQ
Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)	23/09/20	AQ
Waverley Pharma : Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the United States	08/09/20	AQ
Waverley Pharma : Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in Italy	25/08/20	AQ
Waverley Pharma : Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European Countries	30/07/20	AQ
Waverley Pharma : Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Synthetic Library of Chloroquine Analogs to Treat COVID-19	25/06/20	AQ
Waverley Pharma : Announces Reliance on Relief from Filing Requirements for Annual Financial Statements	28/04/20	AQ
Waverley Pharma : Announces Appointment of New President and CEO	03/02/20	AQ
Waverley Pharma : Announces Executive Leadership Changes	08/01/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Waverley Pharma Inc.

Actions

WAVE

CA94357L1058

Communiqués

Filtres